Rameda Announces the Establishment of Glow: A Strategic Expansion into the Thriving Freely Priced Cosmeceutical Market Corporate NewsBy Rameda AdminSeptember 9, 2024
Rameda Announces Price Increase Approvals for All Its Top Products Corporate NewsBy Rameda AdminAugust 7, 2024
Rameda Expands Freely Priced Portfolio with Launch of Ramelact, Egypt’s First Lactase Enzyme Supplement for the treatment of Lactose Intolerance Corporate NewsBy Rameda AdminMay 28, 2024
Rameda Maintains its Impressive Momentum with the Launch of a New Type 2 Diabetes Product, Bolstering its Chronic Portfolio Corporate NewsBy adminNovember 28, 2023
